Bayer Aktiengesellschaft (ETR:BAYN – Get Free Report) shares traded down 4% during mid-day trading on Thursday . The company traded as low as €21.17 ($23.26) and last traded at €21.43 ($23.54). 4,269,244 shares changed hands during mid-day trading, The stock had previously closed at €22.32 ($24.52).
Bayer Aktiengesellschaft Stock Down 5.5 %
The company has a market capitalization of $20.29 billion, a PE ratio of -23.05, a price-to-earnings-growth ratio of 36.39 and a beta of 0.97. The firm’s 50 day simple moving average is €22.40 and its 200 day simple moving average is €22.76.
Bayer Aktiengesellschaft Company Profile
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.
See Also
- Five stocks we like better than Bayer Aktiengesellschaft
- How to Profit From Value Investing
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- How to Use the MarketBeat Stock Screener
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- Investing In Automotive Stocks
- Spotify Stock Eyes Double-Digit Upside—Is Now the Time to Buy?
Receive News & Ratings for Bayer Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.
